imipramine has been researched along with oxotremorine m in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delen, FM; Ehlert, FJ; Liem, HA; Yun, SH | 1 |
| Dean, B; Gibbons, AS; Jeon, WJ; Scarr, E | 1 |
2 other study(ies) available for imipramine and oxotremorine m
| Article | Year |
|---|---|
The interaction of amitriptyline, doxepin, imipramine and their N-methyl quaternary ammonium derivatives with subtypes of muscarinic receptors in brain and heart.
Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Brain; Doxepin; Heart; Imipramine; In Vitro Techniques; Male; N-Methylscopolamine; Oxotremorine; Pirenzepine; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine Derivatives | 1990 |
Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Cerebral Cortex; Depressive Disorder, Major; Disease Models, Animal; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Muscarinic Agonists; Oxotremorine; Pirenzepine; Radiopharmaceuticals; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Tritium | 2016 |